Skip to content

Category: Medical Devices

MaRS Catalyst Fund joins US$9.5-million investment in CellAegis

MaRS Catalyst Fund is investing in CellAegis, a Canadian medical device company with promising technology to help substantially improve patient recovery from heart disease. CellAegis’ autoRIC® device is a portable and easy-to-administer therapy for reducing damage to tissues following a heart attack or cardiovascular procedures. The autoRIC Device has already been approved for use in […]

Read More